Prognosis of Olfactory Dysfunction according to Etiology and Timing of Treatment

Abstract

Objective We evaluated the severity of olfactory impairment according to risk factors, compared responses with risk factors and treatment timing, and investigated prognosis according to treatments. Study design Case series with chart review. Setting Tertiary referral center. Subjects and Methods We retrospectively reviewed medical records of patients complaining of loss of their sense of smell between January 2006 and May 2016. In total, 491 patients were included. We evaluated olfactory function using the Connecticut Chemosensory Clinical Research Center test (threshold test) and Cross-cultural Smell Identification Test. Results Post-upper respiratory infection patients showed better results than those with other risk factors (59.6% recovered). Patients with head trauma (12.5% recovered) and congenital olfactory dysfunction (0% recovered) showed poorer results. Earlier treatment showed better olfactory recovery outcomes for post-upper respiratory infection ( P = .001), head trauma ( P = .022), and nasal/sinus surgery ( P = .009). Xerostomia ( P = .73) and idiopathy ( P = .365) showed no significant difference in terms of treatment timing. The threshold test better reflected subjective recovery than the identification test. The systemic + topical steroid group and the systemic steroid treatment group both showed better smell recovery outcomes than the group with topical treatment alone (both, P < .001). However, there was no significant difference between the systemic treatment group and the systemic + topical treatment group ( P = .978). Conclusions Our findings suggest that the duration of smell loss is important for better olfactory outcomes with most etiologies. Also, the effects of systemic steroids were better than those of topical steroids, regardless of combined treatment.

The Effect of Olfactory Training Using Korean Version Odorants: A Preliminary Study

“…In other words, the progress of regeneration probably differs between the olfactory threshold and olfactory identification. 34) The olfactory system exhibits extraordinary plasticity because of mechanisms that have been extensively investigated at the cognitive as well as the cellular level. 35,36) The mechanisms of neural plasticity in the olfactory system are interesting, because olfactory loss is among the first symptoms of neurodegenerative disorders such as Alzheimer's disease and Parkinson's disease.…”

The use of platelet‐rich plasma in treatment of olfactory dysfunction: A pilot study

“…The etiology of olfactory dysfunction is quite varied, including postviral, post‐traumatic, and idiopathic loss of smell. Unfortunately, with these etiologies, the likelihood of spontaneous recovery is generally poor, with only approximately one‐third of people regaining function and the duration of loss negatively correlating with recovery rate . Treatment for olfactory dysfunction is also limited.…”

Clinical Features of Olfactory Dysfunction in COVID-19 Patients

“…In the present study, the mean duration of olfactory impairment in patients who underwent olfactory training was approximately 3 months. Kim et al 22 reported that better treatment outcomes were achieved in PIOD patients who started olfactory training less than 1 month after olfactory loss. Therefore, we concluded that immediate olfactory training might show better results in COVID-19 infection-associated OD.…”